Actively Recruiting
Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-01-28
200
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Toxoplasmosis is a common infection whose clinical severity can sometimes justify admission to intensive care, especially in immunocompromised patients. This study should make it possible to evaluate the impact of different anti-infective treatment regimens and to highlight clinical-biological and prognostic differences depending on the type of underlying immunosuppression.
CONDITIONS
Official Title
Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient hospitalized in intensive care
- At least 1 organ failure (SOFA score �3 2)
- Positive PCR test for toxoplasmosis from cerebrospinal fluid, blood, bronchoalveolar lavage, or bone marrow within 7 days before or after ICU admission
You will not qualify if you...
- Diagnosis made after death
- Primary outcome data not available
- Patient living and opposed to reuse of their data for this research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cochin hospital
Paris, France, France, 75014
Actively Recruiting
Research Team
C
Clara Vigneron, MD
CONTACT
R
Romain Sonneville, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here